AcelRx Pharmaceuticals is a specialty pharmaceutical company that develops treatments for acute pain management. Among its lead products are DSUVIA and DZUVEO, sublingual tablets for moderate-to-severe pain relief, and ZALVISO, an analgesia system for hospital patients. AcelRx is also studying ARX-02, 4ARX-03, Niyad, and LTX-608, which could provide antiviral treatment for COVID, respiratory distress syndrome, disseminated intravascular coagulation, and acute pancreatitis.